168 related articles for article (PubMed ID: 15469203)
1. Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia.
Fatemi SH; Laurence JA; Araghi-Niknam M; Stary JM; Schulz SC; Lee S; Gottesman II
Schizophr Res; 2004 Aug; 69(2-3):317-23. PubMed ID: 15469203
[TBL] [Abstract][Full Text] [Related]
2. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
3. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.
Barley K; Dracheva S; Byne W
Schizophr Res; 2009 Jul; 112(1-3):54-64. PubMed ID: 19447584
[TBL] [Abstract][Full Text] [Related]
4. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder.
Toro CT; Hallak JE; Dunham JS; Deakin JF
Neurosci Lett; 2006 Sep; 404(3):276-81. PubMed ID: 16842914
[TBL] [Abstract][Full Text] [Related]
5. A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis.
Damadzic R; Bigelow LB; Krimer LS; Goldenson DA; Saunders RC; Kleinman JE; Herman MM
Brain Res Bull; 2001 Jul; 55(5):611-8. PubMed ID: 11576757
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of genes encoding neuronal ion-channel subunits in major depression, bipolar disorder and schizophrenia: implications for pathophysiology.
Smolin B; Karry R; Gal-Ben-Ari S; Ben-Shachar D
Int J Neuropsychopharmacol; 2012 Aug; 15(7):869-82. PubMed ID: 22008100
[TBL] [Abstract][Full Text] [Related]
7. Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.
Cobb JA; O'Neill K; Milner J; Mahajan GJ; Lawrence TJ; May WL; Miguel-Hidalgo J; Rajkowska G; Stockmeier CA
Neuroscience; 2016 Mar; 316():209-20. PubMed ID: 26742791
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression.
Webster MJ; Knable MB; Johnston-Wilson N; Nagata K; Inagaki M; Yolken RH
Brain Behav Immun; 2001 Dec; 15(4):388-400. PubMed ID: 11782105
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression.
Si X; Miguel-Hidalgo JJ; O'Dwyer G; Stockmeier CA; Rajkowska G
Neuropsychopharmacology; 2004 Nov; 29(11):2088-96. PubMed ID: 15238995
[TBL] [Abstract][Full Text] [Related]
10. S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study.
Gos T; Schroeter ML; Lessel W; Bernstein HG; Dobrowolny H; Schiltz K; Bogerts B; Steiner J
J Psychiatr Res; 2013 Nov; 47(11):1694-9. PubMed ID: 23896207
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness.
Feresten AH; Barakauskas V; Ypsilanti A; Barr AM; Beasley CL
Schizophr Res; 2013 Oct; 150(1):252-7. PubMed ID: 23911257
[TBL] [Abstract][Full Text] [Related]
12. Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study.
Davis S; Thomas A; Perry R; Oakley A; Kalaria RN; O'Brien JT
J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):556-60. PubMed ID: 12397151
[TBL] [Abstract][Full Text] [Related]
13. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.
Fatemi SH; Stary JM; Earle JA; Araghi-Niknam M; Eagan E
Schizophr Res; 2005 Jan; 72(2-3):109-22. PubMed ID: 15560956
[TBL] [Abstract][Full Text] [Related]
14. Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder.
Steinacker P; Al Shweiki MR; Oeckl P; Graf H; Ludolph AC; Schönfeldt-Lecuona C; Otto M
J Psychiatr Res; 2021 Dec; 144():54-58. PubMed ID: 34600287
[TBL] [Abstract][Full Text] [Related]
15. Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder.
Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
Transl Psychiatry; 2013 Sep; 3(9):e303. PubMed ID: 24022508
[TBL] [Abstract][Full Text] [Related]
16. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium.
Johnston-Wilson NL; Sims CD; Hofmann JP; Anderson L; Shore AD; Torrey EF; Yolken RH
Mol Psychiatry; 2000 Mar; 5(2):142-9. PubMed ID: 10822341
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
18. Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides.
Torres-Platas SG; Nagy C; Wakid M; Turecki G; Mechawar N
Mol Psychiatry; 2016 Apr; 21(4):509-15. PubMed ID: 26033239
[TBL] [Abstract][Full Text] [Related]
19. mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway.
Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
Transl Psychiatry; 2013 Jun; 3(6):e271. PubMed ID: 23778581
[TBL] [Abstract][Full Text] [Related]
20. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.
Ben-Shachar D; Karry R
PLoS One; 2008; 3(11):e3676. PubMed ID: 18989376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
